Serum neurofilament and glial fibrillary acidic protein in idiopathic and seropositive transverse myelitis

•Approximately 90% of patients with idiopathic transverse myelitis (TM) demonstrated good outcomes (EDSS

Saved in:
Bibliographic Details
Published in:Multiple sclerosis and related disorders 2023-11, Vol.79, p.104957-104957, Article 104957
Main Authors: Lee, Hye Lim, Seok, Jin Myoung, Chung, Yeon Hak, Min, Ju-Hong, Baek, Seol-Hee, Kim, Sung Min, Sohn, Eunhee, Kim, Juhyeon, Kang, Sa-Yoon, Hong, Yoon-Ho, Shin, Ha Young, Cho, Joong-Yang, Oh, Jeeyoung, Lee, Sang-Soo, Kim, Sunyoung, Kim, Su-Hyun, Kim, Ho Jin, Kim, Byung-Jo, Kim, Byoung Joon
Format: Article
Language:English
Subjects:
Glial fibrillary acidic protein
Multiple sclerosis
Myelin oligodendrocyte glycoprotein antibody-associated disease
Neurofilament
Neuromyelitis optica spectrum disorder
Transverse myelitis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Approximately 90% of patients with idiopathic transverse myelitis (TM) demonstrated good outcomes (EDSS
ISSN:2211-0348
2211-0356
DOI:10.1016/j.msard.2023.104957